85541-82-8

Basic information

• Product Name: methyl 5-androsten-3β-ol-17β-carboxylate
• CAS NO: 85541-82-8
• Molecular Weight: 332.483
• Mol File: 85541-82-8.mol
• Article Data: 15

Chemical Properties

• CAS DataBase Reference: methyl 5-androsten-3β-ol-17β-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 5-androsten-3β-ol-17β-carboxylate(85541-82-8)
• EPA Substance Registry System: methyl 5-androsten-3β-ol-17β-carboxylate(85541-82-8)

Safety Data

• Hazardous Substances Data: 85541-82-8(Hazardous Substances Data)

Upstream product

• 15173-68-9 etienic acid 
• 75-36-5 acetyl chloride 
• 7150-18-7 3β-acetoxyetienic acid 
• 616-38-6 carbonic acid dimethyl ester 
• 67-56-1 methanol 
• 73672-02-3 pregnenolone 21-pyridinium iodide 
• 432027-36-6 3β-acetoxy-20-methyl-21.21-diphenyl-pregnadiene-(5.20) 
• 1778-02-5 Pregnenolone acetate 
• 145-13-1 Pregnenolone 
• 25493-69-0 (4aS,6aS,6bR,10S,12aR)-methyl 10-acetoxy-2,2,6a,6b,9,9,12a-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylate 
• 74-88-4 methyl iodide 
• 186581-53-3 diazomethane 
• 124-41-4 sodium methylate 
• 514-50-1 3β-acetoxy-5α,6β-dibromocholestane 

Downstream Products

• 96273-69-7 3β-benzoyloxy-androstene-(5)-carboxylic acid-(17β)-methyl ester 
• 2681-55-2 3-oxo-androst-4-ene-17β-carboxylic acid methyl ester 
• 2098-12-6 methyl 3β-(tosyloxy)androst-5-ene-17β-carboxylate 
• 2097-74-7 3β-Triphenylmethyloxy-androst-5-en-17-β-carbonsaeure-methylester 
• 178213-26-8 17β-carbomethoxy-3,5-dioxo-6-nitrilo-5,6-secoandrostane 
• 178213-28-0 (1S,3aS,4S,5S,7aS)-4-Carbamoylmethyl-5-((R)-2-methoxy-1-methyl-4-oxo-cyclohex-2-enyl)-7a-methyl-octahydro-indene-1-carboxylic acid methyl ester 
• 1402154-18-0 (2S,8S,9S,10R,13S,14S,17S)-tert-butyl 2-benzyl-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-17-carboxylate 
• 1402153-83-6 (2R,8S,9S,10R,13S,14S,17S)-tert-butyl 2-benzyl-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-17-carboxylate 
• 1402153-84-7 (2R,8S,9S,10R,13S,14S,17S)-tert-butyl 2-(4-chlorobenzyl)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-17-carboxylate 
• 1402154-19-1 (2S,8S,9S,10R,13S,14S,17S)-tert-butyl 2-(4-tert-butylbenzyl)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-17-carboxylate 
• 1402153-85-8 (2R,8S,9S,10R,13S,14S,17S)-tert-butyl 2-(4-tert-butylbenzyl)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-17-carboxylate 
• 1402154-20-4 (2S,8S,9S,10R,13S,14S,17S)-tert-butyl 10,13-dimethyl-3-oxo-2-[4-(trifluoromethyl)benzyl]-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1Hcyclopenta[a]phenanthrene-17-carboxylate 
• 1402153-86-9 (2R,8S,9S,10R,13S,14S,17S)-tert-butyl 10,13-dimethyl-3-oxo-2-[4-(trifluoromethyl)benzyl]-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1Hcyclopenta[a]phenanthrene-17-carboxylate 
• 1402153-94-9 (2R,8S,9S,10R,13S,14S,17S)-17-tert-butyl 3-methyl 2-benzyl-10,13-dimethyl-2,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,17-dicarboxylate 

Relevant articles and documents

The first synthesis of Krempene B

The synthesis of Krempene B, which can be isolated from the marine soft coral Cladiella krempfi, is achieved in 23.9% overall yield from commercially available 3β-acetoxy-5-pregnen-20-one by 11 steps. Key transformations include the dienone-phenol rearrangement of steroids and Wittig reaction.

AZASTEROIDS FOR TREATMENT OF TUBERCULOSIS

The present invention provides a compound having the structure: formula (I), for use in combinatoin with an anti-tuberculosis drug for treating a subject infected with M. tuberculosis.

An efficient approach to novel 17-5′-(1′,2′,4′)- oxadiazolyl androstenes via the cyclodehydration of cytotoxic O-steroidacylamidoximes, and an evaluation of their inhibitory action on 17α-hydroxylase/C17,20-lyase

Novel 17-exo-oxadiazoles in the androst-5-ene series were efficiently synthesized in a two-step sequence via the corresponding O-acylamidoxime intermediates (obtained from steroidal 17-carboxylic acids and amidoximes in the presence of coupling reagent), which then underwent tetrabutylammonium fluoride-induced cyclocondensation under mild reaction conditions. The synthesized compounds were subjected to in vitro pharmacological studies to investigate their inhibitory effect on rat testicular C17,20-lyase and their antiproliferative action on four malignant human adherent cell lines (HeLa, MCF7, A2780 and A431). One of the oxadiazolyl derivatives proved to exert significant enzyme-inhibitory action (IC50 = 0.60 μM), while some of the isolated O-acylated amidoxime intermediates displayed high cytotoxic activities on all examined cell lines, with IC50 values in the range 0.22-3.94 μM.